2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 406.791 | 385.990 | 378.642 | 372.909 | 368.289 | 403.310 | 344.190 | 372.675 | 411.715 | 1.319.868 |
Total Income - EUR | 406.795 | 386.245 | 378.646 | 373.060 | 370.762 | 403.320 | 349.233 | 372.685 | 411.903 | 1.981.501 |
Total Expenses - EUR | 396.950 | 385.448 | 366.565 | 362.415 | 358.585 | 386.828 | 341.017 | 369.206 | 407.787 | 1.413.240 |
Gross Profit/Loss - EUR | 9.845 | 798 | 12.081 | 10.645 | 12.177 | 16.491 | 8.216 | 3.478 | 4.115 | 568.261 |
Net Profit/Loss - EUR | 8.054 | 468 | 9.808 | 8.941 | 10.535 | 14.222 | 6.280 | 2.990 | 3.470 | 479.241 |
Employees | 7 | 6 | 6 | 6 | 5 | 5 | 5 | 4 | 5 | 2 |
Check the financial reports for the company - Remedium Srl
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 18.971 | 17.279 | 15.654 | 14.078 | 12.549 | 11.079 | 10.539 | 8.907 | 7.220 | 29.754 |
Current Assets | 135.070 | 107.122 | 115.178 | 132.883 | 123.571 | 141.607 | 131.507 | 141.492 | 135.208 | 1.038.488 |
Inventories | 68.903 | 58.782 | 54.658 | 44.450 | 50.278 | 63.848 | 56.790 | 63.296 | 65.773 | 0 |
Receivables | 46.651 | 15.142 | 41.168 | 59.408 | 43.280 | 54.319 | 34.615 | 45.937 | 35.417 | 441.721 |
Cash | 19.515 | 33.198 | 19.352 | 29.025 | 30.014 | 23.440 | 40.102 | 32.260 | 34.018 | 596.767 |
Shareholders Funds | 45.508 | 749 | 19.711 | 28.291 | 38.279 | 25.435 | 17.245 | 20.288 | 17.417 | 485.481 |
Social Capital | 67 | 67 | 9.851 | 9.670 | 9.483 | 9.303 | 9.097 | 9.125 | 9.097 | 5.000 |
Debts | 108.533 | 123.653 | 116.890 | 121.097 | 97.842 | 127.251 | 124.801 | 130.110 | 125.011 | 582.761 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 1 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
Main CAEN | "6820 - 6820" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Remedium Srl